Home > Insider Trading > Filing (0001209191-15-024246)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
818033	Heron Therapeutics Inc.	HRTX	Pharmaceutical Preparations (2834)	942875566

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1383994	Paul Marshall	123 Saginaw Drive Redwood City CA 94063	Svp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-03-05	70,000	$9.40	70,000	No	4	M	Direct
Common Stock	Disposition	2015-03-05	50,000	$14.40	20,000	No	4	S	Direct
Common Stock	Disposition	2015-03-05	20,000	$15.40	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-03-05	70,000	$0.00	70,000	$9.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
140,000		2023-11-01	No	4	M	Direct

Footnotes

The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of December 16, 2014.
The option granted on November 1, 2013 was a non-plan grant under an agreement with terms substantially the same as applicable to options granted under the Company's 2007 Equity Incentive Plan.
Options vested with respect to 52,500 of the underlying shares on November 1, 2014 and pursuant to the terms of the grant, the unvested portion vests pro rata on a monthly basis over the next three years, equaling 4,375 shares per month.